Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Industry News U.S. Government Expands Smallpox Stockpile With $54 Million VIGIV Contract, International Orders Add $6.6 MillionGlobal Biodefense StaffMarch 25, 2026
Medical Countermeasures Mpox Antiviral Clinical Trial Advances as WHO Extends Global EmergencyGlobal Biodefense StaffJuly 17, 2025
MGB Biopharma Receives 6.4M to Advance Novel Antibacterial Antimicrobial Resistance September 18, 2014 …
